A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PILOT STUDY TO ASSESS THE SAFETY, EFFICACY AND PHARMACODYNAMICS OF CAT-2003 ALONE AND IN COMBINATION WITH A STATIN IN PATIENTS WITH HYPERLIPIDEMIA (PATHWAYS I)
- Registry ID
- CAT-2003-201
- Source registry
- HEALTH_CANADA
- Status
- Ongoing
- Study type
- INTERVENTIONAL
- Sponsor
- CATABASIS PHARMACEUTICALS INC
- Start date
- 2013-08-28
- Last update
- 2013-08-28
Conditions
- HYPERLIPIDEMIA
- HYPERTRIGLYCERIDEMIA
Related clinical trials
- PHASE 1/2A, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE AND MULTIPLE DOSE-ESCALATING STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PHARMACODYNAMIC EFFECTS OF ARO-DIMERPA IN ADULT SUBJECTS WITH MIXED HYPERLIPIDEMIA
- A PHASE 2, OPEN-LABEL TRIAL EVALUATING THE SAFETY, TOLERABILITY AND EFFICACY OF ION775 IN ADULTS WITH HYPERTRIGLYCERIDEMIA
- A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF LY3561774 (SOLBINSIRAN) IN ADULTS WITH SEVERE HYPERTRIGLYCERIDEMIA (SOLARIS-1)
- A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ENLICITIDE DECANOATE COADMINISTERED WITH ROSUVASTATIN IN ADULTS WITH HYPERLIPIDEMIA
- A PHASE III, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY TO ASSESS THE EFFECT OF AZD0780 ON LOW-DENSITY LIPOPROTEIN CHOLESTEROL IN PATIENTS WITH ELEVATED LOW-DENSITY LIPOPROTEIN CHOLESTEROL AND CLINICAL ATHEROSCLEROTIC CARDIOVASCULAR DISEASE OR AT RISK FOR A FIRST ATHEROSCLEROTIC CARDIOVASCULAR DISEASE EVENT
- A PHASE 3 OPEN-LABEL EXTENSION STUDY TO EVALUATE THE LONG-TERM SAFETY AND EFFICACY OF
PLOZASIRAN IN ADULTS WITH HYPERTRIGLYCERIDEMIA (SHASTA-10 STUDY)
View on source registry